Based on Phase 2 trial data, the most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
Preparation during the easy weeks is what separates completers from quitters
1, 2025, and McHugh says about 2,000 new members start a GLP-1 regimen every month
She points to family dynamics, mental health issues like anxiety and stress, especially for young people with social media
Immediate medical attention is required if taste changes are accompanied by: Severe, persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, decreased urination) Severe abdominal pain, particularly if persistent or worsening Symptoms of pancreatitis (severe upper abdominal pain radiating to the back, nausea, vomiting) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Symptoms of hypoglycemia (if also taking insulin or sulfonylureas): shakiness, sweating, confusion, irritability These symptoms may indicate serious adverse effects requiring urgent evaluation, including pancreatitis, gallbladder disease, gastroparesis, or severe dehydration
sometimes used off-label for weight loss) These medicationsall available as injectables, tablets, or oral dropsare accessible today through a clinician and may be a strong option for people who dont qualify for or dont want to wait to get retatrutide with a clinical trial
